BIOCHEMISTRY OF DNA REPAIR AND TRANSCRIPTION
DNA 修复和转录的生物化学
基本信息
- 批准号:6160486
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Summary of work: Cockayne syndrome (CS) is a rare human disease that
is characterized by arrested post-natal growth and resulted in premature
aging and death. Cells from CS individuals are abnormally sensitive to
killing by ultraviolet radiation as well as certain so-called UV-mimetic
chemicals, such as 4-nitroquinoline-1-oxide and
N-acetoxy-2-acetylaminofluorene. This cellular phenotype prompted
extensive studies on the ability of CS cells to carry out nucleotide
excision repair both in intact cells and in cell-free systems. Most
conventional assays, including the use a cell-free system that supports
transcription-independent nucleotide excision repair, indicate no defect
in CS cells. However, CS cells are defective in the enhanced rate of
repair of the template (transcribed) strand relative to the coding
(non-transcribed) strand of transcriptionally active genes. In recent
experiments from this laboratory we have demonstrated that mutations in
the CSB gene are the cause of the transcription coupled repair defect. In
hamster cells homologous to CSB we can transfect with a normal CSB gene
and complement the repair defect. The mechanism of TCR in eukaryotes
remains to be elucidated, and the CSB protein appears.
These observations and discovery of dual function of transcription factor
II H (TFIIH) in transcription and DNA repair, led to the "transcriptional
hypothesis" which postulates that transcription defects are the underlying
basis for the pathology in some human diseases including Cockayne
syndrome. In this laboratory we were interested to test this hypothesis
experimentally, and we have demonstrated the reduced level of RNA
polymerase II (Pol II) transcription in intact and permeabilized CS-B
cells. The molecular mechanism responsible for this deficiency was further
investigated in a cell-free system. We utilized in vitro transcription
assay and determine Pol II transcription activity in extracts prepared
from different CS cell lines in comparison to extracts prepared from
normal cells. We found that in vitro transcription is CS extracts is
highly sensitive to minor damages in template DNA arising during
purification. This deficiency may be complemented by transfection of a
CS-B cell line with normal CSB gene. Studies of transcription in vitro in
a plasmid based system demonstrate a significant transcription defect in
CSB cells. This defect may be related to oxidation damage or structural
changes in the DNA which somehow affects the transcription in CSB cells
but not in normal cells. Experiments in intact cells also demonstrate a
defect in basal transcription which can be complemented by transfection
with the normal CSB gene. Further, these experiments suggest that CSB
cells may have a defect in the assembly of the higher order chromatin
structural organization in conjunction with transcription and DNA repair.
This is supported by the observation that CSB chromatin is much more
sensitive to detergent than normal chromatin.
工作总结: Cockayne综合征(CS)是一种罕见的人类疾病,
其特征是产后生长受阻,
衰老和死亡来自CS个体的细胞对以下物质异常敏感:
紫外线辐射以及某些所谓的紫外线模拟物
化学品,如4-硝基喹啉-1-氧化物和
N-乙酰氧基-2-乙酰氨基芴。这种细胞表型促使
对CS细胞进行核苷酸转移的能力的广泛研究
在完整细胞和无细胞系统中的切除修复。最
常规测定,包括使用无细胞系统,
非转录依赖性核苷酸切除修复,表明无缺陷
在CS细胞中。然而,CS细胞在增强的细胞增殖率方面是有缺陷的。
模板(转录)链相对于编码
转录活性基因的(非转录的)链。近几
我们在这个实验室的实验表明,
CSB基因是转录偶联修复缺陷的原因。 在
与CSB同源的仓鼠细胞,我们可以用正常的CSB基因转染
并补充修复缺陷。真核生物TCR的作用机制
尚待阐明,CSB蛋白出现。
这些观察和转录因子双重功能的发现
II H(TFIIH)在转录和DNA修复中的作用,导致了"转录
该假说假定转录缺陷是
包括Cockayne在内的一些人类疾病的病理学基础
综合征 在这个实验室里,我们有兴趣测试这个假设,
实验上,我们已经证明了RNA水平的降低,
完整和透化CS-B中聚合酶II(Pol II)转录
细胞对这种缺陷的分子机制进行了进一步的研究。
在无细胞系统中研究。我们利用体外转录
分析和确定制备的提取物中Pol II转录活性
与不同CS细胞系制备的浸提液相比,
正常细胞我们发现,在体外转录是CS提取物,
对模板DNA中的微小损伤高度敏感,
洁净.这种缺陷可以通过转染一种
具有正常CSB基因的CS-B细胞系。 体外转录研究
基于质粒的系统显示出在以下方面的显著转录缺陷:
CSB细胞。 这种缺陷可能与氧化损伤或结构损伤有关。
在某种程度上影响CSB细胞转录的DNA变化
而不是在正常细胞中。 在完整细胞中的实验也证明了
可通过转染补充的基础转录缺陷
有正常的CSB基因 此外,这些实验表明,
细胞可能在高级染色质的组装中有缺陷
结构组织与转录和DNA修复结合。
这一点得到了以下观察结果的支持,即CSB染色质比CSB染色质多得多。
比正常染色质对去污剂更敏感。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
V A BOHR其他文献
V A BOHR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('V A BOHR', 18)}}的其他基金
相似海外基金
DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
- 批准号:
10748479 - 财政年份:2024
- 资助金额:
-- - 项目类别:
CAREER: Mechanisms and consequences of epigenome-recruited DNA repair systems in plants
职业:植物中表观基因组招募的 DNA 修复系统的机制和后果
- 批准号:
2338236 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Elucidation of the molecular link between DNA repair and mitochondrial nucleic acid metabolism
阐明DNA修复和线粒体核酸代谢之间的分子联系
- 批准号:
23K07078 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
- 批准号:
10550045 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Structural studies for understanding the mechanism of DNA repair in chromatin
了解染色质 DNA 修复机制的结构研究
- 批准号:
23H05475 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (S)
Multifaceted regulation of the DNA repair machinery and suppression of aberrant transcription by telomere proteins
DNA 修复机制的多方面调控和端粒蛋白异常转录的抑制
- 批准号:
2246561 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant
A role of balanced sex hormone in DNA repair in human melanocytes
平衡性激素在人类黑素细胞 DNA 修复中的作用
- 批准号:
10666307 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
- 批准号:
10651048 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Modeling the Responsiveness of Sensitive Populations to Genotoxic Agents Using DNA Repair Inhibitors
使用 DNA 修复抑制剂模拟敏感人群对基因毒性药物的反应性
- 批准号:
10734425 - 财政年份:2023
- 资助金额:
-- - 项目类别: